Rockwell Medical (RMTI) Non-Current Debt (2013 - 2026)
Rockwell Medical's (RMTI) quarterly Non-Current Debt came in at $8.2 million in Q1 2026, down 4.11% YoY from $8.6 million in Q1 2025, and down 7.01% on a QoQ basis from $8.8 million in Q4 2025.
Rockwell Medical (RMTI) Non-Current Debt (2013 - 2026) Analysis & Trends
Rockwell Medical (RMTI) has 10 years of Non-Current Debt data on file, last reported at $8.2 million in Q1 2026.
- Quarterly Non-Current Debt fell 4.11% year-over-year to $8.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.2 million (down 4.11% YoY) and the FY2025 annual result came in at $8.8 million, up 4.18% from the prior year.
- Non-Current Debt eased to $8.2 million in Q1 2026, from $8.8 million in the prior quarter.
- In the past five years, Non-Current Debt ranged from a high of $11.8 million in Q1 2022 to a low of $503000.0 in Q4 2022.
- A 5-year average of $7.5 million and a median of $8.4 million in 2024 frame the typical range for Non-Current Debt.
- Annual changes were most pronounced in 2022 — Non-Current Debt slumped 96.19% — and 2023, when it surged 1548.71%.
- Tracing RMTI's Non-Current Debt over 5 years: stood at $503000.0 in 2022, then soared by 1548.71% to $8.3 million in 2023, then gained by 2.16% to $8.5 million in 2024, then grew by 4.18% to $8.8 million in 2025, then retreated by 7.01% to $8.2 million in 2026.
- The last three Non-Current Debt figures came in at $8.2 million (Q1 2026), $8.8 million (Q4 2025), and $8.7 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.40 Bn | 43.44 Bn | - | -8.44 Bn |
| 2 | Teva Pharmaceutical Industries | 43.65 Bn | 39.99 Bn | 2.15 Bn | 12.09 Bn |
| 3 | Zoetis | 32.33 Bn | 30.65 Bn | 1.05 Bn | 9.05 Bn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 27.73 Bn |
| 5 | United Therapeutics | 21.99 Bn | 19.32 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.85 Bn | 17.96 Bn | 1.46 Bn | 11.61 Bn |
| 7 | Neurocrine Biosciences | 15.59 Bn | 15.20 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.97 Bn | 11.44 Bn | 798.00 Mn | 3.85 Bn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 130.00 Mn |
| 10 | Rockwell Medical | 29.97 Mn | 5.17 Mn | 3.24 Mn | 7.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 7.24 Mn |
| Mar 31, 2026 | 8.21 Mn |
| Dec 31, 2025 | 8.83 Mn |
| Sep 30, 2025 | 8.74 Mn |
| Jun 30, 2025 | 8.65 Mn |
| Mar 31, 2025 | 8.56 Mn |
| Dec 31, 2024 | 8.47 Mn |
| Sep 30, 2024 | 8.38 Mn |
| Jun 30, 2024 | 8.30 Mn |
| Mar 31, 2024 | 8.27 Mn |
| Dec 31, 2023 | 8.29 Mn |
| Sep 30, 2023 | 3.33 Mn |
| Jun 30, 2023 | 733,000.00 |
| Dec 31, 2022 | 503,000.00 |
| Sep 30, 2022 | 8.96 Mn |
| Jun 30, 2022 | 10.37 Mn |
| Mar 31, 2022 | 11.78 Mn |
| Dec 31, 2021 | 13.19 Mn |
| Sep 30, 2021 | 14.09 Mn |
| Mar 31, 2021 | 21.04 Mn |